Imago Biosciences

25 articles with Imago Biosciences

• Imago Biosciences Doses First Patients In Phase I/II Study Of IMG-7289 In Myelofibrosis

  9/19/2017

• Imago Biosciences Doses First Patients In The Phase IIa Portion Of The Study Of IMG-7289 In Acute Myeloid Leukemia And Myelodysplastic Syndrome

  7/19/2017

• Imago Biosciences Enrolls First Patient In Phase 1/2 Study Of IMG-7289 In Acute Myeloid Leukemia And Myelodysplastic Syndrome

  11/9/2016

• Imago Biosciences Announces Preclinical Data On LSD1 Inhibitor At Annual Meeting Of The American Society of Hematology

  12/7/2015

• SF Startup Imago Biosciences Reels In $26.5 Million

  10/31/2014